Centpropazine
Centpropazine
Centpropazine is a pharmaceutical compound that has been studied for its potential use as an antidepressant. It is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), which means it works by increasing the levels of the neurotransmitters serotonin and norepinephrine in the brain. These neurotransmitters are believed to play a key role in mood regulation and are often targeted by antidepressant medications.
Mechanism of Action
Centpropazine functions by inhibiting the reuptake of serotonin and norepinephrine, thereby increasing their availability in the synaptic cleft. This action is similar to other SNRIs such as venlafaxine and duloxetine. By preventing the reabsorption of these neurotransmitters into the presynaptic neuron, centpropazine enhances neurotransmission and can help alleviate symptoms of depression.
Clinical Uses
While centpropazine has been primarily investigated for its antidepressant properties, its clinical use is not as widespread as other SNRIs. Research into its efficacy and safety profile is ongoing, and it may be considered for patients who do not respond to other treatments.
Side Effects
As with many antidepressants, centpropazine can have side effects. Common side effects may include:
- Nausea
- Dizziness
- Insomnia
- Dry mouth
- Increased sweating
More serious side effects, although rare, can include:
- Hypertension
- Serotonin syndrome
- Increased risk of suicidal thoughts, particularly in young adults
Pharmacokinetics
Centpropazine is metabolized in the liver and excreted primarily through the kidneys. Its half-life and bioavailability can vary depending on individual patient factors such as age, liver function, and concurrent medications.
Research and Development
Centpropazine is still under investigation in various clinical trials to better understand its therapeutic potential and safety profile. Studies are focusing on its efficacy compared to other antidepressants, as well as its long-term effects on patients with chronic depression.
See Also
References
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
